Omada Health
OMDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.9% | 11.7% | 14.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 66.3% | 65.5% | 58% | 66.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2.7% | -4.7% | -12.8% | -12.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.7% | -8.7% | -17.2% | -17.2% |
| EPS Diluted | -0.06 | -0.093 | -0.17 | -0.15 |
| % Growth | 35.2% | 45.5% | -13.3% | – |
| Operating Cash Flow | $0 | $0 | -$0 | – |
| Capital Expenditures | -$0 | -$0 | -$0 | – |
| Free Cash Flow | $0 | $0 | -$0 | – |